Reproductive BioMedicine Online

Reproductive BioMedicine Online is a journal dedicated to exploring the development, growth, and specialization of the human embryo. Its goal is to highlight innovative research in both biological and clinical aspects of human reproduction, which may also include studies involving animals. The journal is designed for a wide range of readers, including researchers, medical professionals, academics, and patients.

International, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#477372

United States

#472867

Health/Womens Health

#546

Traffic sources

Monthly visitors

Articles

Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife a longitudinal cohort study

1 month ago | rbmojournal.com | Maryam Kazemi |Elaine Yu |Lifecourse Epidemiology |Victoria Fitz

KeywordsPolycystic ovary syndromeBoneBody CompositionSkeletal MuscleMetabolismGet full text accessLog in, subscribe or purchase for full access. REFERENCES1. Agrawal, D. ∙ Mohanty, B.B. ∙ Sarangi, R. ... Study of incidence and prevalence of musculoskeletal anomalies in a tertiary care hospital of eastern IndiaJ Clin Diagn Res. 2014; 8:Ac04-062. Bailey, R.L. ∙ Sahni, S. ∙ Chocano-Bedoya, P. ...
The contribution of private and public centres to innovation in fertility care: acknowledging the past and preserving the future

1 month ago | rbmojournal.com | Bart CJM Fauser |Nick Macklon |London Women’s Clinic

Key wordsIVFResearchTrainingInnovationPrivateFrom the late 1970s, assisted reproductive technologies (ART) developed be way of intense collaboration between highly driven clinician and basic scientists (Cohen et al., 2005; Fishel, 2018). The resulting novel treatment options have truly revolutionized fertility care, as beforehand they were largely limited to either ovulation induction, intra-uterine insemination and (micro)surgery.
Decoding embryo development: the impact of clinical variables in morphokinetics and AI quality scoring

Feb 15, 2025 | rbmojournal.com | Jorge Ten |Klaus Wiemer |Alex Mutter |Nerea Díaz |Miguel Herreros |Cristina Hickman | +11 more

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Embryo secretome in predicting embryo quality and in vitro fertilization treatment outcome

Jan 14, 2025 | rbmojournal.com | Silvia Toporcerová |Zuzana Badovská |Mária Mareková |Signe Altmae |Signe Altmäe |Miroslava Rabajdová | +2 more

ReviewArticles in Press104825 1Department of Gynaecology and Obstetrics, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11 Košice, Slovakia 2Center for Assisted Reproduction Gyncare s.r.o., 040 13 Košice, Slovakia 3Medirex, a.s., Holubyho 35 902 01 Pezinok 4Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, 040 11 Košice, Slovakia 5SAFTRA-BioMAI, Pavol Jozef Šafárik University in Košice, 040 11 Košice, Slovakia...
Embryological-clinical classification of female genital tract malformations - a review and update

Dec 10, 2024 | rbmojournal.com | Pedro Acién |Miguel Hernandez |Miguel Hernández |San Juan |Victoria Navarro

Key wordsfemale genital malformationsclassificationuterine malformationsMüllerian anomaliesmesonephric anomaliesgenitourinary embryology1. Most classification systems for female genital malformations essentially refer only to Müllerian (utero-vaginal) anomalies. 2. To properly classify, manage and treat malformations of the female genital tract, it is essential to consider genitourinary embryology. 3.
Rescue of late maturing oocytes in poor prognosis patients: delayed intracytoplasmic sperm injection (DICSI) results in more viable embryos

Nov 28, 2024 | rbmojournal.com | Balsam Al Hashimi |Simon Harvey |Katie Harvey |Elena Linara-Demakakou |Darren Griffin |Kamal Ahuja | +1 more

KeywordsDICSIin vitro maturationmaternal ageoocytepoor prognosisIntroductionControlled ovarian hyperstimulation for in vitro fertilisation (IVF) treatment aims to safely stimulate the growth of multiple ovarian follicles to allow the retrieval of mature, competent oocytes that have progressed to the metaphase II (MII) stage of meiosis that culminates in the extrusion of the first polar body.
Sociodemographic profile of women seeking elective egg freezing when financed by the public healthcare system

Nov 13, 2024 | rbmojournal.com | Université de Lille

Research ArticleArticles in Press104705Open access 1Institut de Biologie de la reproduction, CHU de Lille, France 2Service d'Assistance médicale à la procréation, CHU de Lille, France 3Université de Lille, CNRS, UMR 9193 - SCALab - Sciences Cognitives et Sciences Affectives, F 59000 Lille, France Publication History: Received August 7, 2024; Revised October 28, 2024; Accepted November 2, 2024; Published online November 13, 2024 DOI: 10.1016/j.rbmo.2024.104705Also available on ScienceDirect...
Innovations in reproductive medicine, Gartner hype cycle and Dunning-Kruger effect

Nov 4, 2024 | rbmojournal.com | Alex Polyakov

ArticleArticles in Press104702Open access 1Reproductive Services Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia 2Genea Fertility Melbourne City, Melbourne, Victoria, Australia 3Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia 4Faculty of Philosophy, The University of Oxford, Oxford, UK 5Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 6Biomedical...
Reassessing the conventional fertilisation check: leveraging PGT-A to increase the number of transferrable embryos

Oct 23, 2024 | rbmojournal.com | Balsam Al Hashimi |London Women's Clinic |Milton Keynes

Key wordsabnormal fertilisationembryoeuploidpronucleizygoteAberrant fertilization occurs in many zygotes from IVF or ICSI, often leading to their discard. Some embryos initially deemed aberrant can develop to the blastocyst stage. PGT-A analysis helps identify viable embryos for transfer, increasing the number of available embryos.
Persistence of Müllerian Duct Syndrome: a new AMH mutation discovered in a primary infertility case

Oct 20, 2024 | rbmojournal.com | Le Kremlin-Bicêtre

KeywordsPersistent Müllerian duct syndromeAnti-Müllerian hormoneInfertilityCryptorchidismAzoospermiaExploratory laparoscopyINTRODUCTIONPersistent Müllerian Duct Syndrome (PMDS) is a rare autosomal recessive syndrome caused by mutations in the anti-Müllerian hormone (AMH) or AMH receptor II (AMH-RII) genes, transmitted either in a homozygous or a compound heterozygous manner.